Free Trial

Kirin (OTCMKTS:KNBWY) Announces Earnings Results

Kirin logo with Consumer Staples background

Key Points

  • Kirin Holdings reported $0.24 earnings per share for the quarter, missing analysts' estimates of $0.28 by $0.04.
  • The company's revenue for the quarter was $4.01 billion, significantly lower than the analyst estimate of $608.48 billion.
  • Kirin's stock rose 5.1% following the earnings release, trading at $14.16 with a market capitalization of $11.47 billion.
  • Looking to export and analyze Kirin data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Kirin (OTCMKTS:KNBWY - Get Free Report) posted its earnings results on Thursday. The company reported $0.24 EPS for the quarter, missing analysts' consensus estimates of $0.28 by ($0.04), Zacks reports. Kirin had a net margin of 2.30% and a return on equity of 3.74%. The business had revenue of $4.01 billion during the quarter, compared to analysts' expectations of $608.48 billion.

Kirin Trading Down 0.4%

OTCMKTS:KNBWY traded down $0.06 on Wednesday, reaching $14.39. The company's stock had a trading volume of 47,898 shares, compared to its average volume of 70,343. Kirin has a 12-month low of $12.25 and a 12-month high of $16.25. The company has a quick ratio of 0.72, a current ratio of 1.15 and a debt-to-equity ratio of 0.54. The firm has a market cap of $11.66 billion, a price-to-earnings ratio of 31.98 and a beta of 0.13. The stock has a 50 day moving average price of $13.89 and a 200 day moving average price of $13.98.

About Kirin

(Get Free Report)

Kirin Holdings Company, Limited engages in food and beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, whiskey, spirits, soft drinks, dairy products, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products.

Read More

Earnings History for Kirin (OTCMKTS:KNBWY)

Should You Invest $1,000 in Kirin Right Now?

Before you consider Kirin, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kirin wasn't on the list.

While Kirin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines